
Sign up to save your podcasts
Or


Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding. Author Ayalew Tefferi, MD, of the Mayo Clinic, joins JAMA Associate Editor David Simel, MD, MHS, to discuss diagnosis and treatment of this condition. Related Content:
By JAMA Network4.4
471471 ratings
Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding. Author Ayalew Tefferi, MD, of the Mayo Clinic, joins JAMA Associate Editor David Simel, MD, MHS, to discuss diagnosis and treatment of this condition. Related Content:

137 Listeners

317 Listeners

539 Listeners

697 Listeners

162 Listeners

254 Listeners

885 Listeners

3,347 Listeners

38 Listeners

21 Listeners

12 Listeners

11 Listeners

10 Listeners

16 Listeners

19 Listeners

5 Listeners

7 Listeners

1,145 Listeners

30 Listeners

195 Listeners

9 Listeners

91 Listeners

14 Listeners

5 Listeners

515 Listeners

5 Listeners

368 Listeners

425 Listeners

106 Listeners

18 Listeners

370 Listeners

3 Listeners

318 Listeners

272 Listeners